HOME | CONTACT

See Nektar's R&D pipeline of products in clinical development »
Learn more about our clinical trials »
See Nektar partners and case studies »
News Headlines
Events Calendar
July 28, 2010 Nektar Therapeutics Q2 2010 Financial Results Call
5:00 PM Eastern Time
Listen to this webcast »

Replay Dial Information:
(U.S.) 888-286-8010
(International) 617-801-6888
Passcode - 67523786
June 7, 2010 Nektar Investor Event at ASCO
Chicago, Illinois
7:30 AM – 9:15 AM
View Webcast »
Biographies of Panel Participants »
Awards & Recognitions
Jun. 2010 Dose-Escalation Phase 1 Study of NKTR-105, a Novel PEGylated Form of Docetaxel presented at the 2010 ASCO Annual Meeting by Emiliano Calvo »
Nov. 2009 Nektar in U.S. $1.5 billion licensing deal with AstraZeneca - Nature Reviews »
Sept. 28, 2009 Nektar's Next Step - BioCentury »
 
Site Map Privacy Terms of Use Compliance Policy Trademarks Site Users Guide Copyright Nektar © 2010